|
Market Cap | 106.70M | EPS (ttm) | -0.02 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 5.26 | EPS Q/Q | -493.10% |
Dividend | - | Sales Q/Q | - |
Insider Own | 90.56% | Inst Own | 29.69% |
Insider Trans | 0.00% | Inst Trans | -0.49% |
Short Float | 0.94% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 70.94K | 52W Range | 5.32 - 22.50 |
|
|
Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns the Wolfsberg Lithium Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands. |
|
|
|
Market Cap | 547.48M | EPS (ttm) | -0.53 |
P/E | - | EPS this Y | -13.35% |
Forward P/E | 23.06 | EPS next Y | 73.39% |
PEG | - | EPS past 5Y | - |
P/S | 1.58 | EPS next 5Y | - |
P/B | 3.30 | EPS Q/Q | -1896.66% |
Dividend | - | Sales Q/Q | 22.96% |
Insider Own | 24.52% | Inst Own | 46.46% |
Insider Trans | -2.70% | Inst Trans | 4.00% |
Short Float | 1.92% | Earnings | Mar 11/a |
Analyst Recom | 1.00 | Target Price | 48.75 |
Avg Volume | 80.81K | 52W Range | 25.52 - 42.90 |
|
|
|
Bowman Consulting Group Ltd. operates as a professional services firm delivering innovative engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, survey, land procurement and technical services. The company was founded by Gary P. Bowman on June 5, 1995 and is headquartered in Reston, VA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Labovitz Bruce J | Chief Financial Officer | Mar 21 '24 | Sale | 41.83 | 10,000 | 418,300 | 293,288 | Mar 21 05:54 PM | Labovitz Bruce J | Chief Financial Officer | Mar 19 '24 | Sale | 37.43 | 2,500 | 93,575 | 303,288 | Mar 21 05:54 PM | Hickey Robert Alan | Chief Legal Officer | Mar 18 '24 | Sale | 38.94 | 8,000 | 311,480 | 214,403 | Mar 20 05:15 PM | Bruen Michael | Chief Operating Officer | Mar 05 '24 | Sale | 33.52 | 5,000 | 167,600 | 436,074 | Mar 06 05:48 PM | Bowman Gary | President, CEO and Chairman | Feb 22 '24 | Sale | 33.89 | 2,500 | 84,725 | 1,104,430 | Feb 23 04:33 PM |
|
|
|
|
Market Cap | 78.22M | EPS (ttm) | -5.83 |
P/E | - | EPS this Y | 31.37% |
Forward P/E | - | EPS next Y | 20.71% |
PEG | - | EPS past 5Y | -25.24% |
P/S | 110.16 | EPS next 5Y | - |
P/B | 1.14 | EPS Q/Q | -1103.63% |
Dividend | - | Sales Q/Q | -47.93% |
Insider Own | 63.95% | Inst Own | 10.00% |
Insider Trans | 0.16% | Inst Trans | 3.73% |
Short Float | 0.02% | Earnings | Feb 27/a |
Analyst Recom | 1.00 | Target Price | 72.67 |
Avg Volume | 29.74K | 52W Range | 2.92 - 44.00 |
|
|
|
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Ross Cathy | Director | Jan 10 '24 | Buy | 1.31 | 5,000 | 6,544 | 10,000 | Jan 11 06:00 PM | Baluch Khoso | Director | Dec 29 '23 | Buy | 1.43 | 8,322 | 11,915 | 15,000 | Jan 02 06:00 PM | PFEFFER JEFFREY | Director | Dec 28 '23 | Buy | 1.35 | 10,000 | 13,500 | 15,000 | Dec 29 05:00 PM | Baluch Khoso | Director | Dec 28 '23 | Buy | 1.40 | 1,678 | 2,342 | 6,678 | Jan 02 06:00 PM | Hare Joshua | Chief Scientific Officer | Sep 21 '23 | Option Exercise | 3.00 | 5,000 | 15,000 | 7,828,263 | Sep 22 07:00 PM |
|
|
| |
|
Market Cap | 32.34M | EPS (ttm) | 0.07 |
P/E | 96.02 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 4.27 | EPS Q/Q | 50.33% |
Dividend | - | Sales Q/Q | - |
Insider Own | 73.18% | Inst Own | 15.71% |
Insider Trans | 0.00% | Inst Trans | -0.17% |
Short Float | 1.15% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 69.69K | 52W Range | 3.40 - 14.00 |
|
|
|
Graphjet Technology engages in the manufacture of artificial graphene and graphite, a critical raw material used in a variety of industries, such as biomedical, automobile composition and coating, electronics and home appliances, food and beverage processing, energy storage, batteries in electric vehicles, mechanical strength enhancement, sensors, semiconductors, and digital products. The company is headquartered in Kuala Lumpur, Malaysia. |
|
|
|
Market Cap | 50.32M | EPS (ttm) | -0.88 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 1.09 | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 57.71% | Inst Own | 0.61% |
Insider Trans | 0.00% | Inst Trans | -1.25% |
Short Float | 0.34% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 17.00 |
Avg Volume | 295.07K | 52W Range | 0.63 - 3.49 |
|
|
|
Anghami, Inc. engages in the provision of digital entertainment and online streaming platforms. It includes music, podcasts, music videos, and live events. Its products are available on all devices such as mobile and tablets, desktop and laptop, cars, speakers, Chromecast, PlayStation, wearables, and Apple TV. The company was founded by Edgard Jean Maroun and Elias Nabil Habib on February 14, 2012 and is headquartered in Abu Dhabi, United Arab Emirates. |
|
| |
|
Market Cap | 5.03M | EPS (ttm) | -12.01 |
P/E | - | EPS this Y | 76.49% |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.90 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 63.78% |
Dividend | - | Sales Q/Q | -5.40% |
Insider Own | 0.00% | Inst Own | 4.38% |
Insider Trans | - | Inst Trans | 1.56% |
Short Float | 1.22% | Earnings | Mar 26/a |
Analyst Recom | 3.00 | Target Price | 3.00 |
Avg Volume | 23.33K | 52W Range | 2.68 - 39.60 |
|
|
|
Intrusion, Inc. is a cybersecurity company, which offers customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company was founded by T. Joe Head and G. Ward Paxton in September 1983 and is headquartered in Plano, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Scott Anthony | Chief Executive Officer | Dec 31 '23 | Buy | 0.22 | 1,500 | 330 | 383,980 | Jan 24 03:43 PM | PINSON KIMBERLY | Chief Financial Officer | Dec 31 '23 | Buy | 0.22 | 1,500 | 330 | 34,833 | Jan 24 03:42 PM | GERO JAMES | Director | Nov 08 '23 | Buy | 0.58 | 364,583 | 211,458 | 866,566 | Nov 09 10:24 AM | Scott Anthony | Chief Executive Officer | Nov 08 '23 | Buy | 0.58 | 333,333 | 193,333 | 382,801 | Nov 09 10:23 AM | Hyer Raymond T | 10% Owner | Nov 08 '23 | Buy | 0.58 | 333,333 | 193,333 | 3,331,953 | Nov 13 05:51 PM |
|
|
|
|
Market Cap | 95.28M | EPS (ttm) | -15.51 |
P/E | - | EPS this Y | 115.02% |
Forward P/E | 3.01 | EPS next Y | 184.68% |
PEG | - | EPS past 5Y | 5.32% |
P/S | 61.47 | EPS next 5Y | - |
P/B | 2.32 | EPS Q/Q | 84.45% |
Dividend | - | Sales Q/Q | - |
Insider Own | 54.40% | Inst Own | 13.70% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.88% | Earnings | - |
Analyst Recom | 1.00 | Target Price | 15.50 |
Avg Volume | 37.78K | 52W Range | 2.00 - 18.50 |
|
|
|
Prairie Operating Co. engages in development, exploration, and production of oil, natural gas, and natural gas liquids. It focuses on unconventional oil and natural gas reservoirs located in Colorado focused on the Niobrara and Codell formations. The company is also a crypto company involved in cryptocurrency mining. Prairie Operating was founded by Gary C. Hanna and Edward Kovalik on May 2, 2001 and is headquartered in Houston, TX. |
|
| |
|
Market Cap | 9.50M | EPS (ttm) | -0.30 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.55 | EPS next 5Y | - |
P/B | 1.37 | EPS Q/Q | -5138.89% |
Dividend | - | Sales Q/Q | 42.23% |
Insider Own | 80.23% | Inst Own | 0.04% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 4.25% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 205.23K | 52W Range | 1.20 - 13.99 |
|
|
|
Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. It operates under the Services and Drugs segments. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, articles, and short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China. |
|
|
|
Market Cap | 6.00B | EPS (ttm) | -1.69 |
P/E | - | EPS this Y | 46.31% |
Forward P/E | - | EPS next Y | 41.79% |
PEG | - | EPS past 5Y | -33.39% |
P/S | 1.40 | EPS next 5Y | -5.74% |
P/B | 1.44 | EPS Q/Q | 45.94% |
Dividend | - | Sales Q/Q | 149.94% |
Insider Own | 1.34% | Inst Own | 12.98% |
Insider Trans | 0.00% | Inst Trans | -0.97% |
Short Float | 6.20% | Earnings | Mar 19/b |
Analyst Recom | 2.13 | Target Price | 11.49 |
Avg Volume | 13.58M | 52W Range | 7.51 - 23.62 |
|
|
|
XPeng, Inc. designs, develops, manufactures, and markets smart electric vehicles. It produces environmental friendly vehicles, namely SUVs (the G3), and a four-door sports sedan (the P7). The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China. |
|
|
|
Market Cap | 150.57M | EPS (ttm) | -0.14 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 69.13 | EPS Q/Q | -631.65% |
Dividend | - | Sales Q/Q | - |
Insider Own | 41.91% | Inst Own | - |
Insider Trans | 1.12% | Inst Trans | - |
Short Float | 0.11% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 80.63K | 52W Range | 4.76 - 20.72 |
|
|
|
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. It focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm's initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded on August 26, 2021 and is headquartered in Baltimore, MD. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bay Shore Trust | 10% Owner | Feb 13 '24 | Buy | 7.00 | 138,000 | 966,000 | 5,455,431 | Feb 15 04:11 PM |
|
|
|